Nephrotic syndrome: Molecular and genetic basis

Nephron

Volumn 85, Issue 1, 2000, Pages 8-13

  Fogo, Agnes ^a  

^a VANDERBILT UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

ACEI; Angiotensin; Glomerular epithelial cell; Proteinuria; Sclerosis

Indexed keywords

ANGIOTENSIN; CYTOTOXIN; DIPEPTIDYL CARBOXYPEPTIDASE; GROWTH FACTOR; PROTEIN; REACTIVE OXYGEN METABOLITE;

ANTIGEN ANTIBODY COMPLEX; CAPILLARY WALL; ENDOTHELIUM CELL; EPITHELIUM CELL; GLOMERULUS BASEMENT MEMBRANE; GLOMERULUS CAPILLARY; HUMAN; KIDNEY BLOOD FLOW; MOLECULAR BIOLOGY; NEPHROTIC SYNDROME; PRIORITY JOURNAL; PROTEINURIA; REVIEW;

EID: 0034054609     PISSN: 00282766     EISSN: None     Source Type: Journal    
DOI: 10.1159/000045623     Document Type: Review

References (36)

1. Farquhar MG, Saito A, Kerjaschki D, Orlando RA: The Heymann nephritis antigenic complex: Megalin (gp330) and RAP. J Am Soc Nephrol 1995;6:35-47.
2. Salant DJ: The structural biology of glomerular epithelial cells in proteinuric diseases. Curr Opin Nephrol Hypertens 1994;3:569-574.
3. Morelli E, Loon N, Meyer T, Peters W, Myers BD: Effects of converting-enzyme inhibition on barrier function in diabetic glomerulopathy. Diabetes 1990;39:76-82.
4. kip1, in developing and mature kidneys. Kidney Int 1998;53:892-896.
5. Sharif K, Goyal M, Kershaw D, Kunkel R, Wiggins R: Podocyte phenotypes as defined by expression and distribution of GLEPPI in the developing glomerulus and in nephrotic glomeruli from MCD, CNF, and FSGS. A dedifferentiation hypothesis for the nephrotic syndrome. Exp Nephrol 1998;6:234-244.
6. Barisoni L, Kriz W, Mundel P. D'Agati V: The dysregulated podocyte phenotype: A novel concept in the pathogenesis of collapsing idiopathic focal segmental glomerulosclerosis and HIV-associated nephropathy. J Am Soc Nephrol 1999;10:51-61.
7. Smoyer WE, Mundel P: Regulation of podocyte structure during the development of nephrotic syndrome. J Mol Med 1998;76:172-183.
8. Kemeny E, Mihatsch MJ, Durmuller U, Gudat F: Podocytes loose their adhesive phenotype in focal segmental glomerulosclerosis. Clin Nephrol 1995;43:71-83.
9. Kestila M, Lenkkeri U, Mannikko M, et al: Positionally cloned gene for a novel glomerular protein - nephrin - is mutated in congenital nephrotic syndrome. Mol Cell 1998;1:575-582.
10. Weiher H, Noda T, Gray DA, Sharpe AH, Jaenisch R: Transgenic mouse model of kidney disease: Insertional inactivation of ubiquitously expressed gene leads to nephrotic syndrome. Cell 1990;62:425-434.
11. Dressler GR, Wilkinson JE, Rothenpieler UW. Patterson LT, Williams-Simons L, Westphal H: Deregulation of Pax-2 expression in transgenic mice generates severe kidney abnormalities. Nature 1993;362:65-67.
12. Pelletier J, Bruening W, Kashtan CE, Mauer SM, Manivel JC, Striegel JE, Houghton DC, Junien C, Habib R, Fouser L, et al: Germline mutations in Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell 1991;67: 437-447.
13. Barbaux S, Niaudet P, Gubler MC, Grunfeld JP, Jaubert F, Kuttenn F, Fekete CN, Souleyreau-Therville N, Thibaud E, Fellous M, McElreavey K: Donor splice-site mutations in WTI are responsible for Frasier syndrome. Nat Genet 1997;17:467-470.
14. Deen WM, Bridges CR, Brenner BM, Myers BD: Heteroporous model of glomerular size-selectivity: Application to normal and nephrotic humans. Am J Physiol 1985;249:F374-F389.
15. Myers BD, Winetz JA, Chui F, Michaels AS: Mechanisms of proteinuria in diabetic nephropathy: A study of glomerular barrier function. Kidney Int 1982;21:96-105.
16. Remuzzi A, Perticucci E, Ruggenenti P, Mosconi L, Limonta M, Remuzzi G: Angiotensin converting enzyme inhibition improves glomerular size-selectivity in IgA nephropathy. Kidney Int 1991;39:1267-1273.
17. Comper WD, Glasgow EF: Charge selectivity in kidney ultrafiltration. Kidney Int 1995;47: 1242-1251.
18. Eisenbach GM, Van Liew JB, Boylan JW: Effect of angiotensin on the filtration of protein in the rat kidney: A micropuncture study. Kidney Int 1975;8:80-87.
19. Yoshioka T, Mitarai T, Kon V, Deen WM, Rennke HG, Ichikawa I: Role of angiotensin II in an overt functional proteinuria. Kidney Int 1986;30:538-545.
20. Ruggenenti P, Perna A, Mosconi L, Pisoni R, Remuzzi G: Urinary protein excretion rate is the best independent predictor of ESRF in nondiabetic proteinuric chronic nephropathies. Gruppo Italiano di Studi Epidemiologici in Nefrologia (GISEN). Kidney Int 1998;53:1209-1216.
21. Eddy AA: Experimental insights into the tubulointerstitial disease accompanying primary glomerular lesions. J Am Soc Nephrol 1994;5: 1273-1287.
22. Kees-Folt D, Sadow JL, Schreiner GF: Tubular catabolism of albumin is associated with the release of an inflammatory lipid. Kidney Int 1994;45:1697-1709.
23. Yoshioka T, Shiraga H, Yoshida Y, Fogo A, Glick AD, Deen WM, Hoyer JR, Ichikawa I: 'Intact nephrons' as the primary origin of proteinuria in chronic renal disease: A study in the rat model of subtotal nephrectomy. J Clin Invest 1988;82:1614-1623.
24. Okuda S, Oochi N, Wakisaka M, et al: Albuminuria is not an aggravating factor in experimental focal glomerulosclerosis and hyalinosis. J Lab Clin Med 1992;119:245-253.
25. Tanaka R, Kon V, Yoshioka T, Ichikawa I, Fogo A: Angiotensin converting enzyme inhibitor modulates glomerular function and structure by distinct mechanisms. Kidney Int 1994; 45:537-543.
26. Dantal J, Bigot E, Bogers W, Testa A, Kriaa F, Jacques Y, Hurault de Ligny B, Niaudet P, Charpentier B, Soulillou JP: Effect of plasma protein adsorption on protein excretion in kidney-transplant recipients with recurrent nephrotic syndrome. N Engl J Med 1994;330:7-14.
27. Savin VJ, Sharma R, Sharma M, McCarthy ET, Swan SK, Ellis E, Lovell H, Warady B, Gunwar S, Chonko AM, Artero M, Vincenti F: Circulating factor associated with increased glomerular permeability to albumin in recurrent focal segmental glomerulosclcrosis. N Engl J Med 1996;334:878-883.
28. Kon V, Fogo A, Hellings S, Bills T, Ichikawa I: Bradykinin causes selective efferent arteriolar dilatation during angiotensin I converting enzyme inhibition. Kidney Int 1993;44:545-550.
29. Heeg JE, de Jong PE, van der Hem GK, de Zeeuw D: Angiotensin II does not acutely reverse the reduction of proteinuria by long-term ACE inhibition. Kidney Int 1991;40:734-741.
30. Hunley TE, Julian BA, Phillips JA 3rd, Summar ML, Yoshida H, Horn RG, Brawn NJ, Fogo A, Ichikawa I, Kon V: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996;49:571-577.
31. Yoshida H, Mitarai T, Kawamura T, Kitajima T, Miyazaki Y, Nagasawa R, Kawaguchi Y, Kubo H, Ichikawa I, Sakai O: Role of the deletion of polymorphism of the angiotensin converting enzyme gene in the progression and therapeutic responsiveness of IgA nephropathy. J Clin Invest 1995;96:2162-2169.
32. Jacobsen P, Rossing K, Rossing P, Tarnow L, Mallet C, Poirier O, Cambien F, Parving HH: Angiotensin converting enzyme gene polymorphism and ACE inhibition in diabetic nephropathy. Kidney Int 1998;53:1002-1006.
33. Lee DY, Kim W, Kang SK, Koh GY, Park SK: Angiotensin-converting enzyme gene polymorphism in patients with minimal-change nephrotic syndrome and focal segmental glomerulosclerosis. Nephron 1997;77:471-473.
34. Hunley TE, Julian BA, Phillips JA, Summar ML, Yoshida H, Horn RG, Brown NJ, Fogo A, Ichikawa I, Kon V: Angiotensin converting enzyme gene polymorphism: Potential silencer motif and impact on progression in IgA nephropathy. Kidney Int 1996;49:571-577.
35. Yoshioka T, Ichikawa I, Fogo A: Reactive oxygen metabolites cause massive, reversible proteinuria and glomerular sieving defect without apparent ultrastructural abnormality. J Am Soc Nephrol 1991;2:902-912.
36. Binder C, Weiher H, Exner M; Kerjaschki D: Glomerular overproduction of oxygen radicals in MpV17 gene-inactivated mice causes podocyte foot process flattening and proteinuria: A model of steroid-resistant nephrosis sensitive to radical scavenger therapy. Am J Path 1999; 154:1067-1076.